Evidence map›Paper›PMID 39158182›Full record

SynthesisCancer reports (Hoboken, N.J.)2024

Efficacy and Safety of

Yunxin Wang, Yuhong Ma, Lijuan Zou, Hongwei Lei, Yun Teng, Fuxiu Ye, Feng Zhang, Haichen Zhang

Abstract readMeta-AnalysisReview
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Cancer reports (Hoboken, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yunxin WangDepartment of Radiation Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.ORCID 0009-0001-9591-0298
Yuhong MaDepartment of Radiation Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Lijuan ZouDepartment of Radiation Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Hongwei LeiDepartment of Radiation Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Yun TengDepartment of Radiation Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Fuxiu YeDepartment of Radiation Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Feng ZhangDepartment of Radiation Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Haichen ZhangDepartment of Radiation Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.

Funding

the "Unveiling the Leader" projects of the Liaoning Province 2021JH1/10400051
6 · The paper itself

Abstract

backgroundThe study aimed to assess the efficacy and safety of RECENT FIDINGS: The meta-analysis included six studies and a total of 246 patients. The pooled ORR of tumor response was 63%, and the DCR was 87%. The median PFS was 9.09 months, and the median OS was 13.46 months. The incidence of adverse events of Grade ≥III was 6%.

conclusionIn conclusion, this meta-analysis confirmed that

trial registrationPROSPERO: CRD42023423857.

Indexed as

BrachytherapyIodine RadioisotopesNeoplasm Recurrence, LocalUterine Cervical NeoplasmsChinaEast Asian PeopleFemaleHumansPelvic NeoplasmsIodine-125Iodine Radioisotopes125Ibrachytherapymeta‐analysisradiotherapyrecurrent cervical cancer

Identifiers

PMID39158182
PMCPMC11331501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.